FDA approves Blenrep, a GSK blood cancer drug with unusual history
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Launch prices for new drugs ‘significantly’ exceed inflation, analysis says
Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…
CVS Caremark tells AIDS activists Gilead needs to lower the price of its new HIV drug to get on formularies
For the past three months, CVS Caremark has resisted adding a new Gilead Sciences HIV prevention drug to…
Novo Nordisk board members step down after major shareholder dispute
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
FDA approved fewer drugs in third quarter, analysis finds
The upheaval at the Food and Drug Administration appears to be taking a toll on the pharmaceutical industry,…
FDA announces first nine recipients of priority drug review vouchers
WASHINGTON — The Food and Drug Administration on Thursday announced the first nine recipients of the Commissioner’s National…
Novo Nordisk begins round of layoffs in United States: Reuters
A view shows a Novo Nordisk sign outside its office in Bagsvaerd, on the outskirts of Copenhagen, Denmark,…
Operation Warp Speed II can slash red tape — and save lives
The Food and Drug Administration aims to let only safe and effective drugs reach the US market —…
Largest study of African American brain tissue reveals key Alzheimer gene activity
The prevalence of Alzheimer disease (AD) is approximately two times higher in African Americans (AA) compared to White/European-ancestry…
Ex-FDA regulator Peter Marks joins Eli Lilly
WASHINGTON — Peter Marks, the former top vaccine regulator at the Food and Drug Administration, has joined Eli Lilly…
What will TrumpRx mean for patients? Who saves — and how much
Could “TrumpRx” be the prescription for lower drug prices? President Trump announced a landmark deal with Pfizer to…
Trump pharmaceutical tariff threat lessens after Pfizer deal
U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with…